In the second part of the latest episode of our Recovery of Ukraine series, podcast host Olga Ivanova is joined once again by Oleg Milchenko, LTO Chapter Lead at Roche Ukraine, to discuss the impact of war on clinical studies and patient care in Ukraine.

The conversation centres on the disruption of international clinical trials, its implications for patient access to innovative treatments and Roche’s efforts to support individuals already enrolled in studies. Oleg also shares his views on the regulatory environment & market access in the pharmaceutical industry in Ukraine, in light of therapidly changing regulatory environment.

Looking ahead, Oleg shares his perspective on the role of pharmaceutical companies in Ukraine’s post-war recovery, highlighting the importance of collaboration, adherence to international standards and long-term investment in healthcare innovation.

The latest Soundshot episode is available on our website, Spotify, Apple Podcasts and Amazon Music under the title Wolf Theiss Soundshot.

For further information or tailored advice, please contact us at: [email protected]